Tradestie Institutional Equity Comparison Engine

BAX vs LYRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BAX Overall Edge

BAX Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Baxter International Inc. (BAX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BAX trades at 12.5x Forward P/E with 7.6% operating margin (+5.0% YoY revenue) versus LYRA at N/M Forward P/E and -25032.0% operating margin (-87.2% YoY). In options structure, BAX sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro) against LYRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner BAX
BAX 12.5x vs LYRA N/M Fwd P/E
Growth & Margin Winner BAX
Op Margin 7.6% vs -25032.0% ยท YoY +5.0% vs -87.2%
Momentum & Technical Winner BAX
1Y +39.9% vs -94.3% ยท 52W Pos 71% vs 1%
Options & Structure Winner BAX
CONSOLIDATION (5th %ile IV) vs UNCLASSIFIED (N/A IV)
BAX NYSE
Baxter International Inc.
Surgical & Medical Instruments & Apparatus
$25.83
+1.14% 1D
Market Cap $13.4B
1M Return +3.36%
1Y Return +39.85%
Forward P/E 12.5x
Unified AI Score
46.5 / 100 HOLD
Tech 47.0 Fund 56.0 Flow 71.0 Mom 50.0
LYRA NASDAQ
Lyra Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.49
-62.5% 1D
Market Cap $2.3M
1M Return -62.5%
1Y Return -94.34%
Forward P/E N/M
Unified AI Score
52.2 / 100 HOLD
Tech 60.0 Fund 56.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BAX +39.85% LYRA -94.34% Spread: +79.61 pp (BAX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BAX Revenue LYRA Revenue BAX Op. Margin LYRA Op. Margin Margin Edge
FY2018 $11.1B N/A 14.3% N/A BAX
FY2019 $11.4B N/A 15.6% N/A BAX
FY2020 $11.7B N/A 13.8% N/A BAX
FY2021 $12.2B $0M 11.1% -15303.5% BAX
FY2022 $10.1B $0M -28.3% -4131.0% BAX
FY2023 $10.4B $0M 6.8% -4308.1% BAX
FY2024 $10.6B $0M 0.1% -6280.8% BAX
FY2025 $11.2B $0M -2.7% -7794.5% BAX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BAX (8) vs LYRA (2)
Institutional Metric BAX LYRA Criterion Row Winner
Market Capitalization Scale $13.4B $2.3M Larger Scale BAX
Trailing P/E Ratio Valuation 12.2x N/M Lower Multiple BAX
Forward P/E Ratio Valuation 12.5x N/M Lower Multiple BAX
Revenue Growth (YoY) Growth +5.0% -87.2% Higher Growth BAX
Operating Margin (TTM) Profitability 7.6% -25032.0% Higher Margin BAX
Net Profit Margin Profitability -6.2% 0.0% Higher Margin LYRA
Return on Equity (ROE) Capital Efficiency -9.0% -404.5% Higher ROE BAX
52-Week Range Position Momentum 71% ($16โ€“$30) 1% ($0โ€“$38) Stronger Trend BAX
Beta / 30D Volatility Risk Regime 0.95ฮฒ ยท 47% Vol 0.33ฮฒ ยท 248% Vol Lower Realized Risk BAX
Unified Institutional Score Composite Signal 46.5 / 100 (HOLD) 52.2 / 100 (HOLD) Higher Composite LYRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BAX vs LYRA Buy Guide
BAX CONSOLIDATION
74d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live BAX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LYRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LYRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BAX nor LYRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.